These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12584667)

  • 1. The renin-angiotensin-aldosterone system and the eye in diabetes.
    Strain WD; Chaturvedi N
    J Renin Angiotensin Aldosterone Syst; 2002 Dec; 3(4):243-6. PubMed ID: 12584667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and retinal vascular disorders: role of the renin-angiotensin system.
    Wilkinson-Berka JL
    Expert Rev Mol Med; 2004 Jul; 6(15):1-18. PubMed ID: 15387897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies.
    Moravski CJ; Skinner SL; Stubbs AJ; Sarlos S; Kelly DJ; Cooper ME; Gilbert RE; Wilkinson-Berka JL
    Am J Pathol; 2003 Jan; 162(1):151-60. PubMed ID: 12507898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new view of diabetic retinopathy: a neurodegenerative disease of the eye.
    Barber AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):283-90. PubMed ID: 12657367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier.
    Saishin Y; Saishin Y; Takahashi K; Melia M; Vinores SA; Campochiaro PA
    J Cell Physiol; 2003 May; 195(2):210-9. PubMed ID: 12652648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetic retinopathy--the mechanisms of the ocular neovascularization and the development of anti-angiogenic drugs].
    Kuroki M; Kawakami M
    Nihon Rinsho; 1999 Mar; 57(3):584-9. PubMed ID: 10199138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.
    Sjølie AK; Chaturvedi N
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S42-6. PubMed ID: 12140727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.
    Wilkinson-Berka JL; Kelly DJ; Gilbert RE
    J Vasc Res; 2001; 38(6):527-35. PubMed ID: 11740151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Renin-Angiotensin system and vascular disease in diabetes.
    Deinum J; Chaturvedi N
    Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin system and diabetic retinopathy.
    Kohner EM
    Klin Wochenschr; 1992; 69 Suppl 29():25-7. PubMed ID: 1614187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor during hypoglycemia in patients with type 1 diabetes mellitus: relation to cognitive function and renin-angiotensin system activity.
    Kristensen PL; Høi-Hansen T; Boomsma F; Pedersen-Bjergaard U; Thorsteinsson B
    Metabolism; 2009 Oct; 58(10):1430-8. PubMed ID: 19573885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of vascular endothelial growth factor and down-regulation of pigment epithelium-derived factor messenger ribonucleic acid levels in leptin-exposed cultured retinal pericytes.
    Yamagishi S; Inagaki Y; Amano S; Okamoto T; Takeuchi M
    Int J Tissue React; 2002; 24(4):137-42. PubMed ID: 12779248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
    Zheng Z; Chen H; Xu X; Li C; Gu Q
    Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.